Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Currently watching
View:
Post by Oden6570 on Feb 02, 2022 2:30pm

Currently watching

Biden announcement he is creating Cancer Cabinet, goal cutting death rate in half ! Go TLT Go
Comment by CAinPlap on Feb 02, 2022 2:43pm
UTA article and Biden announcement on same day hopefully has some spillover to TLT.
Comment by StevenBirch on Feb 02, 2022 2:46pm
Personally I don't want government anywhere near cancer or TLT.
Comment by Pandora on Feb 02, 2022 2:54pm
You could be right there. If it results in a big funding pool for Pfizer again it could prioritize a whole new road to go down and not necessarily in the right direction -- and then there are the fruits of the lobbyists.
Comment by CancerSlayer on Feb 02, 2022 4:35pm
  Big Pharma & Big Govt have always been close relatives, but it's only a matter of time imo that TLT ultimately gets adopted by Big Pharma & becomes the new precious arrival to the family...as long as the trial results continue to behave ; )
Comment by enriquesuave on Feb 02, 2022 4:45pm
If we continue to show amazing results, the Biden's relaunch of " Cancer Moonshot" could make us shine like never before.  IMO
Comment by Mikee3003 on Feb 02, 2022 4:57pm
A move off the TSXV (as we all know) and a head office relocation to Boston/Cambridge, MA would help immensely! Just my 2 cents. Mikee
Comment by skys1 on Feb 02, 2022 7:27pm
I  don't see a move to Boston/Cambridge in the future, especially now with Dr Vera on board. However, Roger has wanted to get off the Venture to a more senior exchange for years.
Comment by Mikee3003 on Feb 02, 2022 7:46pm
Perhaps in the not to distant future, assuming trials stay on track.....TLT's new digs AF1QipOTTEgPuQO_WnAZEaTPcsvBtetqG_O5nVSTuOqe=w114-h86-k-no!7i1600!8i1200!4m9!1m2!2m1!1snovartis+corporate+office+usa!3m5!1s0x89c3a88bb1dd073f:0x675e33a60d792c84!8m2!3d40.8082407!4d-74.3886369!15sCh1ub3ZhcnRpcyBjb3Jwb3JhdGUgb2ZmaWNlIHVzYSIDiAEBkgEWcGhhcm1hY2V1dGljYWxfY29tcGFueQ All the best, Mikee
Comment by Gooseybear on Feb 03, 2022 8:21am
Agreed. Brandon should stay away. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250